Name: Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (sdAb-Fc-sdAb)
SKU: HCAB-039
Rating: 5 (1 reviews)

Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (sdAb-Fc-sdAb, Tetravalent Heavy Chain-only Antibody, Tetravalent HCAb) is symmetric protein with two pairs of single domain antibodies (sdAb), from anti-CD64 and anti-HER2 antibodies, fused to the N-terminus and C-terminus of the Fc separately. This BsAb is bispecific, tetravelant, 2+2 antigen-binding valency. It can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD64 & HER2

Type

sdAb-Fc-sdAb

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors

Host Animal 1

llama

Host Animal 2

llama

Targets

Target 1

CD64

Gene ID

1048

UniProt ID

A0A024R0K5

Alternative Names

CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100

Target 2

HER2

Alternative Names

Ganglioside GD2; GD2; Ganglioside; Disialoganglioside GD2

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (sdAb-Fc-sdAb) (HCAB-039). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (sdAb-Fc-sdAb) (CAT#: HCAB-039)

Specifications

Targets

Customer Reviews and Q&As